Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation
Abstract Background Small cell lung cancer (SCLC) is an aggressive malignancy with distinct molecular subtypes defined by transcription factors and inflammatory characteristics. This follow-up study aimed to validate the unique metabolic phenotype in achaete-scute homologue 1 (ASCL1)-driven SCLC cel...
Saved in:
| Main Authors: | Anna Solta, Büsra Ernhofer, Kristiina Boettiger, Christian Lang, Zsolt Megyesfalvi, Theresa Mendrina, Dominik Kirchhofer, Gerald Timelthaler, Beata Szeitz, Melinda Rezeli, Clemens Aigner, Arvand Haschemi, Lukas W. Unger, Balazs Dome, Karin Schelch |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Cancer & Metabolism |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40170-025-00382-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High circulating activin A plasma levels are associated with tumour stage and poor survival in treatment-naive lung squamous cell cancer patients
by: Katharina Sinn, et al.
Published: (2025-01-01) -
Making Sense of the Northern Powerhouse
by: Danny MacKinnon
Published: (2020-05-01) -
A Love Supreme: Pigalle powerhouse
by: Eunice Tudela de Azevedo
Published: (2025-06-01) -
An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis
by: Xiaolu Yang, et al.
Published: (2025-02-01) -
Attentive Self-supervised Contrastive Learning (ASCL) for plant disease classification
by: Getinet Yilma, et al.
Published: (2025-03-01)